Syntheses of hemoprotein models that can be covalently attached onto electrode surfaces by click chemistry

Article abstract of DOI:10.1021/jo062349w

(Chemical Equation Presented) Five alkyne-containing hemoprotein models have been synthesized in a convergent manner. Sonogashira coupling was used to introduce the alkyne functional group on the proximal imidazole before or after being attached on the po

Full text of DOI:10.1021/jo062349w

Syntheses of Hemoprotein Models that can be Covalently Attached
onto Electrode Surfaces by Click Chemistry
Richard A. Decre´au, James P. Collman,* Ying Yang, Yilong Yan, and Neal K. Devaraj
Department of Chemistry, Stanford UniVersity, Stanford, California 94305-5080
jpc@stanford.edu
ReceiVed NoVember 14, 2006
Five alkyne-containing hemoprotein models have been synthesized in a convergent manner. Sonogashira
coupling was used to introduce the alkyne functional group on the proximal imidazole before or after
being attached on the porphyrin. One model was immobilized onto a gold electrode surface via copper-
(I)-catalyzed azide-alkyne cycloaddition (Sharpless click chemistry).
Introduction
allowing rapid electron delivery.4a,c To allow a slow and
controlled rate of electron transfer as in the enzyme, we proposed
to tailor the length and conjugation of azide-terminated alkyl
chains that form self-assembled monolayers (SAM) coating the
electrode. Such attachment has been achieved by the use of
copper(I)-catalyzed azide-alkyne cycloaddition, a form of
Cytochrome c oxidase (CcO) is the heme/copper oxidase in
the respiratory chains of mitochondria and aerobic bacteria that
performs the 4e- reduction of dioxygen to water.1 On the basis
of crystal structures,2a,b our group has designed several models
that structurally mimic the active site of the enzyme.3a,d Past
electrocatalytic studies of O2 reduction with these models have
been conducted on an edge-plane-graphite electrode. Though
convenient, this method relies on poorly defined physisorbed
catalyst films that are in direct contact with the electrode
(4) (a) Collman, J. P.; Boulatov, R.; Sunderland, C. J. In The Porphyrin
Handbook; Academic Press: Boston, 2003; Vol. 11, Chapter 63, pp 1-49.
(b) Collman, J. P.; Boulatov, R.; Sunderland, C. J.; Fu, L. Chem. ReV. 2004,
104, 561. (c) Boulatov, R.; Collman, J. P.; Shiryaeva, I. M.; Sunderland,
C. J. J. Am. Chem. Soc. 2002, 124, 11923.
(5) Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Angew. Chem., Int. Ed.
2001, 40, 2004
(1) Ferguson-Miller, S.; Babcock, G. T. Chem. ReV. 1996, 96, 2889.
(2) (a) Iwata, S.; Ostermeier, C.; Ludwig, B.; Michel, H. S. Nature 1995,
376, 660. (b) Yoshikawa, S.; Shinzawa-Itoh, K.; Nakashima, R.; Yaono,
R.; Yamashita, E.; Inoue, N.; Yao, M.; Fei, M. J.; Libeu, C. P.; Mizushima,
T.; Yamagushi, H.; Tomizaki, T.; Tsukihara, T. Science 1998, 280, 1723.
(3) (a) Collman, J. P.; Bro¨ring, M.; Fu, L.; Rapta, M.; Schwenniger, R.;
Straumanis, A. J. Org. Chem. 1998, 63, 8082. (b) Collman, J. P.; Bro¨ring,
M.; Fu, L.; Rapta, M.; Schwenniger, R.; Straumanis, A. J. Org. Chem. 1998,
63, 8084. (c) Collman, J. P.; Sunderland, C.; Boulatov, R. Inorg. Chem.
2002, 41, 2282. (d) Collman, J. P.; Decre´au, R. A.; Zhang, C. J. Org. Chem.
2004, 69, 3546.
(6) (a) Collman, J. P.; Devaraj, N. K.; Chidsey, C. E. D. Langmuir 2004,
20, 1051. (b) Collman, J. P.; Devaraj, N. K.; Eberspacher, T. A.; Chidsey,
C. E. D. Langmuir 2006, 22, 2457. (c) Lummerstorfer, T.; Hoffmann, H.
J. Phys. Chem. B 2004, 108, 3963. (d) Lee, J. K.; Chi, Y. S.; Choi, I. S.
Langmuir 2004, 20, 3844. (e) Deveraj, N. K.; Decre´au, R. A.; Ebina, W.;
Collman, J. P.; Chidsey, C. E. D. J. Phys. Chem. B 2006, 110, 15955. (f)
Yasseri, A. A.; Syomin, D.; Loewe, R. S.; Lindsey, J. S.; Zaera, F.; Bocian,
D. F. J. Am. Chem. Soc. 2004, 126, 15603. (g) Loewe, R. S.; Ambroise,
A.; Muthukumaran, K.; Padmaja, K.; Lyjenko, A. B.; Mathur, G.; Li, Q.;
Bocian, D. F.; Misra, V.; Lindsey, J. S. J. Org. Chem. 2004, 69, 1453.
10.1021/jo062349w CCC: $37.00 © 2007 American Chemical Society
Published on Web 03/22/2007
2794
J. Org. Chem. 2007, 72, 2794-2802

Syntheses of Hemoprotein Models
FIGURE 1. Click Chemistry on Surfaces. Reagents and conditions: (a) sodium ascorbate, Cu(I), R-CCH, where R ) ferrocene, DNA, a hemoprotein
model such as 1-5 (example with 5b in Scheme 7).
FIGURE 2. Alkyne-containing iron porphyrins 1-5 with increasing structural complexity for covalent attachment onto Au surfaces and the
corresponding key alkyne-containing imidazole synthons (6a,b) that models 2-5 have in common.
Sharpless “click” chemistry5 that we and others have adapted
for the functionalization of surfaces (Figure 1).6a-e The condi-
tions required for such reactions are mild and chemoselective,
allowing for compatibility with a large number of functional
groups.5,6a-e Moreover, this method is a practical alternative to
previous immobilization methods on gold surfaces6f,g because
it affords quantitative yields and no side products.5,6a-e
azide-functionalized electrodes. The structural complexity is
gradually increased from model 1 to model 5 (Figure 2) to
revisit, under the regime of slow electron transfer, the role played
by each key component of the CcO active site in the reduction
of dioxygen. From a simple iron porphyrin (model 1, that we
previously clicked on a SAM),6e we have constructed a built-in
proximal base mimicking His376 (model 2). Then, a series of
distal superstructures were added to a R3â-porphyrin atropiso-
mer. Three simple picket fences in model 3 are designed to
This present study is aimed at designing and synthesizing
alkyne-containing CcO models and at clicking these models on
J. Org. Chem, Vol. 72, No. 8, 2007 2795

Decre´au et al.
SCHEME 1. Synthesis of TMSAlk-Ester (12)a
a Reagents and conditions: (a) formamide, 155 °C, 4 h, 34%; (b) acrylonitrile, vacuum, 190 °C, 2 h, 74%; (c) 3-bromomethylphenyl-3-methylcarboxylate,
MeCN, 4.5 h, 100 °C, 48% (10), 80% (14); (d) CH3ONa/CH3OH, rt, 45 min, 48%; (e) trimethylsilylacetylene, Pd(PPh3)4, CuI, Et3N, THF, rt, 75% (12), 88%
(13), 70% (14).
SCHEME 2. Deprotection of Ester and Alkyne Functions in 12: Synthesis of Alk-Acid 16a
a Reagents and conditions: (a) 1.5 N KOH, THF/CH3OH/H2O 1:1:2 vol, 1 h; (b) AcOH, excess H2O, 10 min, 85% (from 12), 48% (from 14); (c) KF or
K2CO3, CH3OH, rt, 4 h, quantitative; (d) HCl, reflux, quantitative; (e) trimethylsilylacetylene, Pd(PPh3)4, CuI, NEt3, THF, rt, 88%; (f) LiI, acetone, rt, 24
h, 50%; (g) CH3ONa/CH3OH/H2O, rt 1.5 h, 60%; (h) (COCl)2, MeCN, DMF (cat.), rt, 2-4 h, 80% quantitative.
stabilize the oxygen complex with respect to 2 because of the
hydrophobic environment provided by the t-Bu groups and the
stabilizing hydrogen bond between dioxygen and a proton of
an amide. Then, CuI in a trisimidazole environment is added
(model 4, mimicking CuB, His240, His290, and His291) at a
biomimetic distance from the Fe center (ca. 5 Å). The final
2796 J. Org. Chem., Vol. 72, No. 8, 2007

Syntheses of Hemoprotein Models
SCHEME 3. (A) Synthesis of Trisimidazole-alkyne-Tailed Model 4 and (B) Synthesis of Picket-Fence-Tailed Model 3 and
“Flat”-Tailed Model 2a
a Reagents and conditions: (a) 6a or 6b, MeCN/THF 2:1 vol, rt, 30 min, 70-80%; (b) NH3-saturated MeOH/CH2Cl2 3:7 vol, 65%; (c) N-methyl imidazole
acyl chloride,3c MeCN-THF, 70%; (d) (i) FeBr2, THF/MeOH, reflux, 1 h (24b, 25) or 10 h (22), (ii) EDTA, H2O (for Fe-24b only), ca. 80%; (e) CuPF6(MeCN)4,
MeCN, THF, rt, 10 min, quantitative; (f) pivaloyl chloride, THF, Et2NC6H5, rt, 1 h, 88%.
model and closest structural analogue of the cytochrome c
oxidase active site (model 5a) was designed to have one
imidazole cross-linked to a phenol mimicking Tyr244.
The site chosen for introducing the alkyne function is the
para position of the phenyl ring that is grafted on carbon 5 of
the proximal imidazole tail. This strategy depends on an
imidazole synthon 6 that is crucial for models 2-5 to undergo
click chemistry. During the convergent synthesis of models 2-5,
the coupling of the acetylene to the imidazole ring can be carried
out either before (6b) or after (6a) being attached to the
porphyrin. With such a location for the alkyne, the electrons
tunneling from the electrode through the alkyl chain are expected
to reach the iron center of the immobilized bimetallic catalyst
first.
with Br2 leading to bromoacetophenone I-Br 8, which subse-
quently was treated with formamide to give imidazole I-Im 9
in 45% yield. The Horvath protection strategy7 conducted on 9
led to I-Mich 7 in a regiospecific manner. Two equally efficient
(7) Horvath, A. Synthesis 1994, 102; ibid. 1995, 1183.
(8) Sonogashira, K.; Tohada, Y.; Hagira, N. Tetrahedron Lett. 1975, 4467
(9) (a) Free acid-sensitive alkyne could no longer sustain harsh HCl
refluxing conditions previously used for the imidazole ester hydrolysis.3c
Instead, LiI or saponification was more appropriate. (b) This delicate step
requires starting from a pure ester precursor, free of Pd contaminants, and
also prohibits long reaction times or a high concentration of NaOH solution.
(c) No reaction of acyl chloride with alkyne was noticed unlike in ref 9d,e.
(d) Brownstein, S.; Morrison, A.; Tan, L. K. J. Org. Chem. 1985, 50, 2796.
(e) Martens, H.; Janssens, F.; Hoornaert, G. Tetrahedron 1975, 31, 177. (f)
Cu can be removed by acidic treatment but not Pd. (g) Porphyrin 30-mono
could also be recycled and used for the synthesis of 30-bis following a
method reminiscent of the synthesis of 2 + 1 species 32a,c,d (not shown).3d
(h) For simplification, only the cis regioisomer of bisimidazolyl-porphyrin
synthon 30 is depicted in Scheme 5. The reaction of porphyrin 23b with
N-methyl imidazole acyl chloride also leads to the trans regioisomer and
to mono- and trisimidazolyl porphyrins (30-mono and 30-tris). (i) No side
product was noticed from the metalation of alkyne-containing species with
iron(II) and especially Cu(I) salts. (j) The position of the alkyne function
allowed a click reaction to proceed.
Results and Discussion
The first stage in the synthesis of 12, the ester precursor of
the proximal imidazole tail 6a,b, involved the preparation of
the Michael acceptor I-Mich 7 (Scheme 1, route A). This was
prepared by acid-catalyzed bromination of 4-iodoacetophenone
J. Org. Chem, Vol. 72, No. 8, 2007 2797

Decre´au et al.
SCHEME 4. Sonogashira Coupling onto Iodo-porphyrina
a Reagents and conditions: (a) Zn(OAc)2, CHCl3/MeOH, 2:1 vol, rt, 2 h, 92-95%; (b) trimethylsilylacetylene, CuI, Pd(PPPh3)4, Et3N, THF, rt, 18 h,
quantitative; (c) HCl, CH2Cl2, rt, 15 min, 92% quantitative; (d) NH3-saturated CH3OH/CH2Cl2, 1:3 vol, rt, 3 days, 65%; (e) CH2Cl2, CH3OH, K2CO3, rt, 16
h, quantitative.
SCHEME 5. Synthesis of the CcO Model Having a Tyr244 Mimic Following a 2 + 1 Approacha
a Reagents and conditions: (a) 2 equiv of N-methyl imidazole acyl chloride,3c MeCN-THF, rt, 20 min, 70%; (b) (i) HCl gas; (ii) 31ac, MeCN/THF, rt,
70%; (c) (i) 20 equiv of BBr3, CH2Cl2, -78 °C, 30 min, then 0 °C, 1 h, (ii) MeOH, H2O, -78 °C, 30 min, then 0 °C, 1 h; (d) HCl, CH2Cl2, rt, 1 h, 80%;
(e) (i) FeBr2, THF/MeOH, reflux, 1 h, (ii) EDTA, H2O, rt, 15 min, 80%; (f) Cu(MeCN)4PF6, MeCN/THF, rt, 10 min, quantitative.
routes were followed to obtain TMSAlk-Ester 12 from I-Mich
7. Route A involved the quaternization of 7 (leading to I-q 10),
cyanoethyl deprotection (leading to I-Ester 11), and Sonogashira
alkyne coupling8 leading to TMSAlk-Ester 12.
In route B, Sonogashira coupling is conducted first on I-Mich
7 leading to the alkyne-containing imidazole TMSAlk-Mich 13
in 75% yield which is then quaternized and deprotected leading
to TMSAlk-q 14 and TMSAlk-Ester 12, respectively. Sono-
gashira coupling was also carried out on imidazole salt I-q 10
despite its low solubility and led to 14.
I-acid 15. The acid-sensitive alkyne-ester 129a was deprotected
by saponification in 1.5 N NaOH (or K2CO3/MeOH) at room
temperature followed by neutralization with acetic acid and led
to the alkyne-deprotected species Alk-Acid 16.9b The use of
milder reagents such as LiI under refluxing conditions also
effected both deprotection reactions, whereas K2CO3 or KF led
to 17 resulting from a selective deprotection of the alkyne. An
alternative was to run the alkyne coupling on the poorly soluble
iodo-imidazole I-acid 15, leading to TMSAlk-Acid 18, followed
by treatment with a nucleophile giving 16. The most efficient
method to synthesize 16 was achieved by the simultaneous
removal of TMS, ester, and cyanoethyl protective groups in 14.
Ester deprotection (Scheme 2) in the robust imidazoles I-ester
11 was carried out in refluxing acid and led quantitatively to
2798 J. Org. Chem., Vol. 72, No. 8, 2007

Syntheses of Hemoprotein Models
porphyrin 30.9g,h Efficient separation of the regioisomers of this
alkyne-containing synthon was achieved on rotating chroma-
tography plates (chromatotron) without decomposition of the
porphyrins. However, 30 appeared unstable on preparative TLC
plates, unlike CcO models bearing the other imidazole tails
reported previously.3d After mandatory reprotection of the
imidazole pickets of cis regioisomer 30 by acidification,3b,d
reaction with a methyl-protected tyrosine imidazole picket acyl
chloride3d yielded the protected 2 + 1 species 32a. Phenol
deprotection of 32a with BBr3 led to a mixture of 32b and a
compound that corresponds to a bromoalkene derivative, as
shown by mass spectrometry with an additional peak at m/z )
1444. Integration of the signal corresponding to the benzylic
methylene on the NMR spectrum shows that the contaminant
is present in 10-25%. Separation by chromatography could not
be achieved because they have similar polarities. Click chemistry
on the SAM-coated electrode using a metalated version of this
mixture appeared to be the only way to remove the bromoal-
kene-containing porphyrin: the model containing an alkyne was
clicked on the electrode, whereas the bromoalkene side product
did not react and remained in solution. To overcome these
problems, the syntheses of phenol-protected imidazole synthons
31b,c bearing various protective groups (Scheme 6) and the
corresponding 2 + 1 porphyrin intermediates 32c,d (Scheme
5) were undertaken. Trityl (Tr) and p-methoxybenzyl (PMB)
were chosen as protective groups because they offer a good
compromise between robustness and lability under various acidic
conditions.11a-c They were chosen because they could possibly
be sufficiently acid-resistant during the steps where acid is
necessary or generated in small amounts. These steps are the
neutralization with 1 equiv of acetic acid after saponification
of the imidazole ester leading to 35b,c, the acyl chloride
synthesis leading to 31b,c, and the condensation reaction of
31b,c with the bisimidazolyl porphyrin 30 in preacidified media
leading to 32c,d. However, the PMB and Tr protective groups
display enough acid sensitivity to be removed under mild
conditions to prevent side reactions on the proximal alkyne.
Reaction of phenol-imidazole ester 3312 with p-methoxyben-
zyl bromide or trityl bromide, in the presence of potassium
carbonate, led to imidazole 34b,c, respectively. After saponifica-
tion and careful neutralization, imidazole acids 35b,c were
converted into acyl chlorides 31b,c under anhydrous conditions.
Reaction of 31b,c with the bisimidazolyl porphyrin 30 proceeded
as with OMe-protected phenol 31a (Scheme 6). Both protective
groups turned out to be too labile to resist the acidic conditions
in the 2 + 1 condensation between 31b,c and the bisimidazolyl
porphyrin 30 (although they were sufficiently robust to achieve
purification of the imidazole ester precursors 34b,c by long
chromatography). Surprisingly, when this reaction was carried
out with a large excess of 31b,c, the phenol deprotected species
32b was isolated in 50% yield. Such a yield was still acceptable
considering that two side reactions may occur: an intramolecular
reaction in the phenol-deprotected version of 36b,c leading to
a δ-lactone and an intermolecular esterification reaction between
phenol-porphyrin 32b and acyl chloride 31b,c (and subsequent
SCHEME 6. Synthesis of the Imidazole Picket Having a
Tyr244 Mimica
a Reagents and conditions: (a) 4-methoxybenzyl bromide (for 34b), trityl
bromide (for 34c), K2CO3, THF, rt, 24 h, 70% (34bc); (b) (i) 1.5 N NaOH,
MeCN/THF/H2O, (ii) AcOH, H2O, 70%; (c) (COCl)2, MeCN, DMF (cat.),
rt, 3 h, 80%.
This triple deprotection reaction was carried out in a CH3ONa/
CH3OH/H2O (1:1:0.1 mol) mixture in 60% yield. Finally,
imidazole acyl chlorides 6a,b were prepared by reaction of
oxalyl chloride with their carboxylic acid precursors 15 and
16.3c,9c-e
The synthesis of models 3-5 represents significant modifica-
tions to the general synthetic scheme reported earlier for the
synthesis of CcO models3a-d because of the presence of the
alkyne function. The iodo- or alkyne-tail acyl chlorides 6a and
6b reacted with porphyrin R3FâA 193b (Scheme 3A) or
trisphenyl o-aminophenyl porphyrin 2010a (Scheme 3B) leading
to porphyrins R3FâXT 21a,b (X ) I, CCH) and 22 (tailed “flat”
porphyrin), respectively. The three distal amines were depro-
tected to give the R3-amino synthon R3AâXT 23a,b (X ) I,
CCH). This was used as a platform for reaction with N-
methylimidazole acyl chloride3c or pivaloyl chloride10a,b leading
to trisimidazole-tailed porphyrin 24a,b and picket-fence-tailed
porphyrin 25, respectively.
The introduction of the alkyne function was also carried out
on the iodo-imidazole-tailed porphyrins 21a or 24a (Scheme
4). Prior protection of the porphyrin with zinc was mandatory
to prevent metalation of the porphyrin by Cu or Pd from
occurring during the coupling. After reaction of zinc porphyrins
26a,b with trimethylsilylacetylene in the presence of CuI and
Pd0 catalysts, zinc was removed by bubbling HCl through the
solution of porphyrins 27a,b.9f The TMS protective group was
removed in 28b by treatment of the porphyrin with a solution
of K2CO3 leading to 24b. None of the four steps involved in
the Sonogashira coupling on tetrakisimidazolyl porphyrins 24a
could be monitored by TLC because the polarities of the reactant
24a and the product 24b are the same. This is unlike the
coupling reaction carried out on less-polar zinc tristrifluoro-
acetamidoporphyrin 26a. Interestingly, once the protected alkyne
group had been coupled to the porphyrin R3FâIT 21a, the TMS
protective group remained stable during all subsequent steps
of the synthetic scheme (Scheme 4), such as the deprotection
of the distal amines in 28a leading to 29. This offered substantial
advantages for the purification of porphyrin intermediates
(solubilty and separation of regioisomers).
The preparation of model 5 having a Tyr244 mimic followed
the 2 + 1 strategy previously reported for the CF3 counterpart
(Scheme 5).3d Reaction of the freshly prepared N-methylimid-
azole acyl chloride picket3c with 23b led to the bisimidazolyl
(11) (a) Greene, T. W.; Wuts, P. G. M. In ProtectiVe Groups in Organic
Synthesis, 3rd ed.; Wiley: New York, Chichester, Weinheim, Brisbane,
Toronto, Singapore, 1999; Chapter 3, pp 246-287. (b) Kocienski, P. J. In
The Protecting Groups, corrected ed.; Geor Thieme Verlag: Stuttgart, New
York, 2000; Chapter 2.4, pp 42-68. (c) Kocienski, P. J. In The Protecting
Groups, 3rd ed.; Geor Thieme: Stuttgart, New York, 2004; Chapter 4.3,
pp 230-285.
(10) (a) Collman, J. P.; Brauman, J. I.; Doxsee, K. M.; Halbert, T. R.;
Bunnenberg, E.; Linder, R. E.; Lamar, G. N.; Delgaudio, J.; Lang, G.;
Spartalian, K. J. Am. Chem. Soc. 1980, 102, 4182. (b) Collman, J. P.; Gagne,
R. R.; Reed, C. A.; Halbert, T. R.; Lang, G.; Robinson, W. T. J. Am. Chem.
Soc. 1975, 97, 1427.
(12) Collman, J. P.; Wang, Z.; Zhong, M.; Zeng, L. J. Chem. Soc., Perkin
Trans. 1 2000, 8, 1217.
J. Org. Chem, Vol. 72, No. 8, 2007 2799

Decre´au et al.
SCHEME 7. (A) Clicking Model 4 onto an Electrode Surface and (B) Characterization of Immobilized Catalyst 4 by Cyclic
Voltammetrya
a Reagents and conditions. (A): (a) (i) DMSO/H2O, 5b, CuSO4-TBTA, sodium ascorbate, 30 min, (ii) rinse with DMSO and buffer. Mixed monolayer
was formed from N3(CH2)16SH and CH3(CH2)15SH. (B): Cyclic voltammogram of immobilized CcO model 5b (surface coverage: 4.4 × 10-11 mol cm-2).14b
Scan rate: 300 mV/sec. Plain, Fe-32a; dashed, Fe/Cu-32a (model 5b).
oligomerization reactions with other phenol-deprotected versions
of 31b,c) that may not be favored sterically. The small amount
of the porphyrins 32c,d that could be isolated by chromatog-
raphy was easily and quantitatively deprotected by acidic
treatment leading to 32b.
Before metalation and immobilization of the catalysts, the
free-base models were characterized and purified according to
the standards of porphyrinoid and porphyrin chemistry previ-
ously established.3a,b,10a,b,13 The metalation of porphyrins 22,
24b, 25, and 32a,b with FeBr2 was adapted from previous
methods (Schemes 2, 3, and 5)3c and was carried out in refluxing
THF/methanol mixtures followed by washing with EDTA to
remove the distal Fe atom coordinated to the imidazoles
(Schemes 3A and 5). No side reactions were observed during
metalation with free-base porphyrins, neither on the alkyne
(models 1-5) nor on the phenol (model 5).9i Copper insertion
in Fe-24b, Fe-32a, and Fe-32b was achieved by reaction with
1 equiv of CuPF6(CH3CN)4 leading to models 4, 5a, and 5b,
respectively (Schemes 3A and 5). NMR characterization of
models 2-5 and porphyrin intermediates Fe-24b, Fe-32a, and
Fe-32b was made possible by reacting the complexes with CO
leading to diamagnetic low-spin Fe-CO adducts.3c
Immobilization of models 1-5 by click chemistry with
alkyl-azide-functionalized electrodes was conducted in a
water-DMSO mixture in the presence of a CuI catalyst for 30
min (Scheme 7A). The surfaces were cleaned by two washes
with DMSO. Immobilization of the models by covalent linkage
to the alkyl chain through a robust triazole ring has been
demonstrated by means of cyclic voltammetry and IR spectros-
copy (Scheme 7B), as was previously shown with ferrocene.6a,e
Cyclic voltammetry of immobilized species Fe-32a and Fe/Cu-
32a (model 5b) clearly shows a broad reversible couple assigned
to iron and copper centers in these models.14 Immobilization
(13) Collman, J. P.; Decre´au, R. A. Org. Lett. 2005, 7, 975.
2800 J. Org. Chem., Vol. 72, No. 8, 2007

Syntheses of Hemoprotein Models
min, then ca. 3 equiv of NaH (0.133 g) was added portionwise.
The resulting mixture was stirred at 0 °C for 2 h, then 2.2 equiv of
4-methoxybenzyliodide (ca 1.0 g) or trityl bromide was added at
once. The resulting mixture was stirred for 24 h. Two-thirds of the
solvent was removed under reduced pressure. Then the vessel was
cooled again, and an excess of triethylamine and cool water (20
mL) was added. After extraction with CH2Cl2 (3 × 200 mL) and
drying (MgSO4), the solvents were distilled and the residue was
subjected to chromatography [SiO2, 3 × 15 cm, gradient elution,
hexane/CH2Cl2 (1:2 vol), CH2Cl2 100%, and CH2Cl2/CH3OH (95:5
vol)]. 34b (0.240 g, 38%) (yellow oil); 34c (0.367 g, 43%).
3-(2-Trityloxy-phenyl)-3H-imidazole-4-carboxylic Acid Ethyl
Ester (Tr-O-Im-Ester, 34c): 1H NMR (500 MHz, CDCl3) δ (ppm)
7.87 (d, 1H, J ) 1.0 Hz), 7.33 (d, 1H, J ) 1.0 Hz), 7.22-7.28 (m,
15H), 7.18 (d, 1H, J ) 7.5 Hz, J ) 2 Hz), 7.00 (t, 1H, J ) 7.0 Hz,
J ) 1.0 Hz), 6.92 (t, 1H, J ) 7.5 Hz, J ) 1.0 Hz), 6.63 (d, 1H,
J ) 8.5 Hz, J ) 1.5 Hz), 4.28 (q, 2H, J ) 7.0 Hz), 1.25 (t, 3H, J
) 7.0 Hz); 13C NMR (125 MHz, CDCl3) δ (ppm) 160.0, 151.4,
143.6, 142.3, 136.9, 129.1, 128.74, 128.65, 128.0, 127.64, 127.58,
125.6, 121.4, 120.8, 91.4, 60.7, 14.4; MS (ESI+) m/z ) 474.9 [M]+,
MS (ESI-) m/z ) 473.1 [M - H]•- (calcd for C31H26N2O3 474.5);
HPLC-MS (200 µL/min, mobile phase H2O/CH3CN, gradient
2-95%, 35 min); Rt ) 29.1 min; TLC (SiO2, hexane/ethyl acetate
6:4 vol); Rf 0.5.
Ester Hydrolysis Procedures for Acid-Sensitive Imidazoles.
A solution of imidazole ester (1.4 mmol;TMSAlk-Ester, 12, 0.543
g; PMBO-Ester, 34b, 0.492 g; TrO-Ester, 34c, 0.665 g) in THF/
CH3OH (2:1 vol, 10 mL) was mixed with 1.5 N NaOH solution,
and the resulting mixture was stirred at room temperature for 1 h.
Then, only 1.0 equiv of acetic acid (with respect to NaOH, ca. 200
µL) was slowly added to the mixture containing the acid-sensitive
PMBO- or TrO-imidazole pickets to neutralize the mixture,
followed by an excess of water (200 mL) causing the imidazole to
precipitate. It was isolated by filtration and dried under a vacuum.
Yield: Alk-Acid, 16, 0.360 g, 85%; PMBO-Acid, 35b, 0.431 g,
85%; TrO-Acid, 35c, 0.500 g, 80%.
of 5b monitored by grazing-angle infrared spectrometry shows
no evidence of the azide stretch at 2100 cm-1 (data not shown).
The surface coverage was electrochemically determined to be
approximately 4.4 × 10-11 mol/cm2.14
Conclusions
A general method has been developed to prepare hemoprotein
models bearing an alkyne functionality to allow their im-
mobilization by click chemistry. The efficiency of this reaction,
particularly for electrode surface functionalization, has been
demonstrated with complex molecules such as cytochrome c
oxidase models. Models 1-5 that bear an alkyne function on
the proximal side should lead to a better understanding of the
contribution of each redox-active component in the CcO active
site during the 4e- reduction of dioxygen under a slow regime
of electron delivery. Electrocatalytic studies with models 1-5
will be reported elsewhere.14
Experimental Section
General Sonogashira Coupling Procedure. Imidazole (6 mmol,
I-Mich, 7, 1.9 g; I-Ester, 11, 2.5 g; I-q, 10, 3.3 g), CuI (22 mol
%), Pd(PPh3)4 (10 mol %), and 3.0 equiv of Et3N (2.5 mL) were
mixed in THF (100 mL). The resulting suspension was degassed
(five pump-thaw cycles), and 7 equiv of trimethylsilylacetylene
was added (6 mL). The mixture was stirred for 16 h. The progress
of the reaction was monitored by TLC and was indicated by the
formation of a large amount of white precipitate (triethylammonium
iodide). The solvent was removed under reduced pressure and the
residue was subjected to chromatography (SiO2, eluent CH2Cl2/
CH3OH 195:5 vol). The reaction conducted on iodo-porphyrins
(70 µmol scale) used a 1:0.5:1:3 ratio of zinc-protected iodo-
porphyrin (26a,26b)/Pd(PPh3)4/CuI/Et3N and a 100 mg/20 mL
concentration in porphyrin. Chromatography (SiO2)/eluents CH2-
Cl2 (27a), gradient elution of CH2Cl2/MeOH (100:2-100:6 vol)
(27b). Yield: TMSAlk-Ester, 12, 1.7 g, 75%; TMSAlk-Mich, 13,
1.5 g, 88%; TMSAlk-q, 14, 1.94 g, 73%; porphyrin 27a, 0.097 g,
99%; porphyrin 27b, 0.096 g, 98%.
3-{5-[4-(Trimethyl-silanylethynyl)-phenyl]-imidazol-1-ylme-
thyl}-benzoic Acid Methyl Ester (TMSAlk-Ester, 12): 1H NMR
(400 MHz, CDCl3) δ (ppm) 7.92 (d, 1H, J ) 7.00 Hz), 7.67 (s,
1H), 7.58 (brs, 1H), 7.34 (t, 1H, J ) 8.0 Hz), 7.30 (AA′BB′, 4H,
J ) 8.5 Hz), 7.14 (brs, 1H), 7.09 (d, 1H, J ) 6.0 Hz), 5.16 (s, 2H),
3.87 (s, 3H), 0.21 (s, 9H); 13C NMR (100 MHz, CDCl3) δ (ppm)
166.4, 139.0, 137.1, 132.5, 131.2, 131.1, 129.5, 129.4, 128.7, 128.1,
122.9, 104.3, 95.8, 52.6, 48.8, 0.2; MS (ESI+) m/z ) 389.7 [M]+
(calcd for C23H24N2O2Si 388.5); TLC (silica, CH2Cl2/CH2Cl2 95:5
vol); Rf ) 0.25; Mp ) 136-138 °C.
R3-(o-4-(3-Methylimidazolyl)-amidophenyl)-â-(o-3-(1-(5-p-tri-
methylsilyl acetylenyl phenyl)imidazolylmethyl)benzamidophenyl)
Zinc Porphyrin. ([Zn(R3(N-MeIm)âTMSAlk-T)], 27b): 1H NMR
(500 MHz, CDCl3) δ 9.13 (d, 1H, J ) 8.0 Hz), 8.85 (m, 6H), 8.74
(d, 2H, J ) 4.5 Hz), 8.57 (d, 2H, J ) 8.5 Hz), 8.43 (d, 1H, J ) 7.5
Hz), 8.07 (m, 5H), 7.81 (m, 7H), 7.62 (s, 2H), 7.52 (m, 3H), 7.42
(t, 1H, J ) 7.5 Hz), 7.08 (t, 1H, J ) 7.5 Hz), 6.94 (d, 2H, J ) 8.5
Hz), 6.84 (s, 2H), 6.74 (s, 1H), 6.44 (d, 1H, J ) 7.5 Hz), 5.86 (d,
2H, J ) 8.5 Hz), 5.15 (s, 2H), 5.06 (s, 1H), 4.66 (s, 1H), 3.78 (s,
2H), 3.42 (s, 6H), 3.36 (s, 3H), 2.69 (s, 1H), 0.11 (s, 9H); MS
(ESI-) m/z ) 1416.5 [M]•- (calcd for C81H64N16O4SiZn 1416.4);
UV/vis (CH2Cl2) λmax (10-3 ꢀ, M-1 cm-1) 412 (48), 434 (466),
564 (21); TLC (SiO2, NH3-saturated CH2Cl2); Rf ) 0.15.
3-[5-(4-Ethynyl-phenyl)imidazol-1-ylmethyl]-benzoic Acid (Alk-
Acid, 16): 1H NMR (500 MHz, CD3OD) δ (ppm) 7.85 (d, 1H, J )
1.0 Hz), 7.82 (t, 1H, J ) 7.5 Hz, J ) 1.5 Hz), 7.69 (s, 1H), 7.38
(AA’BB’, 4H), 7.26 (t, 1H, J ) 7.5 Hz), 7.10 (d, 1H, J ) 1.0 Hz),
6.98 (d, 1H, J ) 8.0 Hz, J ) 1.0 Hz), 5.33 (s, 2H), 3.53 (s, 1H);
MS (ESI+) m/z ) 303.7 [M + H]+; HR-MS (m/z) ) 303.1136
[M+H]+; MS (ESI-) m/z ) 301.1 [M - H]•- (calcd for C19H14N2O2
302.3267); HPLC-MS (Vydac, 200 mL/min, mobile phase H2O/
CH3CN, gradient 20-95% in CH3CN (20 min); Rt 14.6 min; TLC
(silica, CH3OH 100%); Rf 0.65; mp ) 262-265 °C; FT-IR (KBr)
1665 cm-1
.
General Procedure for the Attachment of a Proximal Imid-
azole Tail. To a suspension of imidazole tail acyl chloride
hydrochloride3c (1.164 mmol; IT-Cl 6a, 0.472 g; AlkT-Cl 6b, 0.416
g) in dry MeCN (10 mL) (sonicated to brake the aggregates) was
slowly added a solution of aminophenylporphyrin R3FâA 193b (up
to 1 equiv, 1.12 g) or TPMAPP 2010a (0.73 g) in MeCN (up to 10
mL). The resulting mixture that progressively turned green was
stirred for 20 min. Dichloromethane was added (100 mL), and the
mixture was washed with sodium bicarbonate and water (the color
went back to purple). The solvent was evaporated, and the residue
was subjected to chromatography: SiO2 gel built with CH2Cl2,
eluent (1) CH2Cl2, (2) gradient of CH2Cl2/CH3OH (up to 97:3 vol).
Average yield obtained for R3FâI-T, 21a (1.4 g, 90%); R3FâAlk-
T, 21b (1.3 g, 89%); TPI-T, 22b (0.946 g, 80%); TPAlk-T, 22a
(0.851 g, 80%).
R3-(o-Trifluoroacetamidophenyl)-â-(o-3-(1-(5-p-acetylenylphe-
nyl)imidazolyl methyl) benzamidophenyl)-porphyrin, R3FâAlk-T
(21b): 1H NMR (400 MHz, CDCl3) δ (ppm): 8.91 (d, 2H, J ) 4.4
Hz), 8.78 (m, 6H), 8.62 (m, 4H), 8.05 (d, 1H, J ) Hz), 7.96 (d,
2H, J ) 7.2 Hz), 7.90 (m, 5H), 7.61 (m, 4H), 7.50 (s, 2H), 7.44 (s,
2H), 6.92 (d, 2H, J ) 8.5 Hz), 6.81 (s, 1H), 6.61 (s, 1H), 6.48 (d,
2H, J ) 8.5 Hz), 6.46 (s, 1H), 6.30 (m, 2H), 6.10 (d, 1H, J ) 6.5
General Phenol Protection. A solution of phenol-imidazole ester
33 (0.430 g, 1.8 mmol) in THF (60 mL) was cooled at 0 °C for 30
(14) Collman, J. P.; Devaraj, N. K.; Decre´au, R. A.; Yang, Y.; Yan, Y.;
Ebina, W.; Eberspacher, T. A.; Chidsey, C. E. D. Science 2007, 315, 1565.
J. Org. Chem, Vol. 72, No. 8, 2007 2801

Decre´au et al.
Hz), 4.16 (s, 2H), 3.00 (s, 1H), -2.68 (s, 2H); 19F NMR (376 MHz,
CDCl3) δ (ppm) -77.22 (s, 6F), -77.74 (s, 3F); MS (ESI+) m/z )
1248.2 [M + H]+, (ESI-) m/z ) 1246.2 [M - H]•- (calcd for
C69H43F9N10O4 1247.13); UV-vis. (CH2Cl2) λ (10-3 × ꢀ/ mol-1
L cm-1) 290 (15.2), 352 (10.3), 374 (13.0), 402 (sh, 37.0), 420
(141.7), 484 (65.7), 514 (8.0), 548 (2.3), 588 (2.6), 648 (0.8); TLC
(silica, CH2Cl2/CH3OH 96:4 vol); Rf 0.35; mp (CH3CN) 200 °C
(decomp.).
General Procedure for the Hydrolysis of Distal Amides. To
a solution of R3FâXTail porphyrins (0.34 mmol; R3FâIT, 21a,
0.450 g; R3FâAlkT, 21b, 0.423 g; R3FâTMSAlkT, 28a, 0.449 g)
in CH2Cl2 (24 mL) cooled at 0 °C and protected from light was
slowly introduced a cold NH3-saturated CH3OH solution (13 mL).
The resulting mixture was stirred for 2 to 3 days. After addition of
CH2Cl2 (100 mL), washings with water (2 × 100 mL), and drying
over MgSO4, the solvents were then distilled. The residue was
subjected to chromatography: SiO2 gel, built with CH2Cl2, 20 × 5
cm; loading of porphyrin in solution in CH2Cl2; gradient elution
of CH2Cl2/CH3OH 200:0-200:2.0 vol. The target porphyrin moves
at 200:2.0 vol. Yields in R3AâXT 23a,b vary according to the initial
concentration in NH3 and the reaction time (50-80%). Average
yield found for R3AâI-T, 23a, 0.202 g, 56%; R3AâAlkT, 23b, 0.192
g, 59%; R3AâTMSAlkT, 29, 0.196 g, 56%.
R3-(o-Aminophenyl)-â-(o-3-(1-(5-p-acetylenylphenyl)imid-
azolylmethyl)benzamido-phenyl)-porphyrin, R3AâAlk-T (23b):
1H NMR (500 MHz, CDCl3) δ 8.89 (m, 9H), 8.08 (d, 1H, J ) 7.5
Hz), 7.87 (t, 1H, J ) 8.0 Hz), 7.74 (d, 3H, J ) 7.5 Hz), 7.57 (m,
4H), 7.52 (s, 1H), 7.12 (m, 6H), 6.89 (d, 2H, J ) 8.0 Hz), 6.84 (s,
1H), 6.79 (s, 1H), 6.48 (d, 2H, J ) 8.0 Hz), 6.29 (t, 1H, J ) 8.0
Hz), 6.21 (m, 2H), 6.16 (d, 1H, J ) 8.0 Hz), 3.93 (s, 2H), 3.54 (s,
2H), 3.50 (s, 4H), 2.99 (s, 1H), -2.66 (s, 2H); MS (ESI+) m/z )
959.6 [M + H]+ (calcd for C63H46N10O 959.4); UV/vis(CH2Cl2)
λmax (10-3ꢀ, M-1 cm-1) 420 (241), 516 (16); HPLC-MS (Vydac,
200 mL/min, mobile phase H2O/CH3CN, gradient 20-95% in CH3-
CN (20 min)); Rt ) 27 min; TLC (SiO2, NH3-saturated CH2Cl2);
Rf ) 0.67.
General Procedure for the Attachment of Distal Imidazole
Pickets. To a suspension of imidazole acyl chloride (105 mg, 0.58
mmol) in acetonitrile (20-35 mL) was slowly added a solution of
porphyrin (29, 100 mg, 0.097 mmol; 23a, 212 mg, 0.20 mmol)
and diethylaniline (51 µL, 0.32 mmol; for 24a, 95 µL, 0.60 mmol)
in CH3CN/THF (1:1 vol; for the synthesis of 28b, 5 mL; for 24a,
10 mL). After the addition, the reaction mixture was stirred for
1-2 h. The solution was diluted with CH2Cl2 (∼150-200 mL)
and washed with 50% saturated aqueous NaHCO3 and water. The
organic layer was dried over MgSO4, filtered, and evaporated to
dryness. The solid residue was subjected to chromatography (SiO2,
20 × 3 cm). For 28b: gradient elution of CH2Cl2/MeOH (100:2-
100:6 vol). The target compound moves at 100:5 vol. Yield: 0.098
g, 75%. For 24a: gradient elution of CH2Cl2/MeOH (100:2-100:
10 vol). The target compound moves at 100:10 vol. Yield: 0.165
g, 60%.
Rt ) 21.9 min; TLC (SiO2, NH3-saturated CH2Cl2); Rf ) 0.15; mp
(CH3CN) 240-250 °C (decomp.).
General Procedure for the Metalation of Porphyrins with
Iron. A mixture of free base porphyrin (7.3-7.8 µmol, ca. 10 mg)
and 3 equiv. FeBr2 (6 mg) in MeOH/THF (1:4 vol., 8 mL) was
heated for 1h at reflux. The volume was reduced to a 1/third then
0.1 M aqueous Na2. EDTA (1 mL) was introduced and the resulting
mixture was stirred for 10 min. Then the volume was expanded
with benzene (30 mL), water was added (20 mL) and stirring was
continued for 10 more min. The organic phase was then washed
with water (4 × 10 mL), dried by addition of Na2SO4 with stirring
for 10 min, then filtered through a glass wool plug. Solvents were
evaporated under reduced pressure. Yields: 80%-quantitative.
cis-R2-(o-4-(3-Methylimidazolyl)-amidophenyl)-R-(o-4-(3-(2-
methoxyphenyl)imidazole)-5-benzamidophenyl)-â-(o-3-(1-(5-p-
acetylenylphenyl)imidazolylmethyl)benzamidophenyl) Iron(II)
Porphyrin, ([Fe(II)R2(N-MeIm)R(N-MeOPhIm)âAlk-T)],(Fe-
32a): 1H NMR (500 MHz, CDCl3/1 atm CO) δ 9.03 (d, 1H, J )
8.4 Hz), 8.68 (m, 9H), 8.43 (d, 1H, J ) 8.2 Hz), 8.40 (d, 1H, J )
6.4 Hz), 8.21 (m, 3H), 7.94 (d, 1H, J ) 7.3 Hz), 7.80 (m, 7H),
7.69 (m, 3H), 7.65 (s, 2H), 7.51 (m, 3H), 7.47 (t, 2H, J ) 7.3 Hz),
7.06 (t, 2H, J ) 7.70 Hz), 7.00 (d, 1H, J ) 7.1 Hz), 6.91 (m, 5H),
6.48 (d, 1H, J ) 7.5 Hz), 5.71 (d, 2H, J ) 8.2 Hz), 3.96 (s, 1H),
3.72 (m, 2H), 3.62 (s, 3H), 3.58 (s, 3H), 3.38 (s, 3H), 2.93 (s, 1H),
2.34 (s, 1H), 1.93 (s, 1H), 1.41 (s, 1H); MS (ESI+) m/z ) 1430.6
[M]+ (calcd for C84H60FeN16O5 1430.4); UV/vis (CH2Cl2) λmax
(10-3ꢀ, M-1 cm-1) 426 (228), 534 (9).
General Procedure for Distal Metalation with Copper. To a
solution of iron trisimidazolyl picket porphyrin (24b, 32a, 32b) in
THF (1 mL) was added 1 equiv of Cu(MeCN)4PF6 (from a stock
solution of 12 mg of Cu(I) salt in 120 µL of MeCN). After 10 min
(occasionally stirring the solution manually), the solvents were
removed.
Copper(I) [cis-R2-(o-4-(3-Methylimidazolyl)-amidophenyl)-R-
(o-4-(3-(2-methoxyphenyl)imidazolyl)-amidophenyl)-â-(o-3-(1-
(5-p-acetylenylphenyl)imidazolylmethyl)benzamidophenyl) Iron
Porphyrin] Hexafluorophosphate, {Cu(I)[Fe(II)(R2(N-MeIm))
R(N-(PhOMe)Im) âAlk-T]}+{PF6}-, Fe/Cu-32a, 5b: 1H NMR
(500 MHz, THF-d8/MeCN-d3/CDCl3 (9:1:3 vol)/1 atm CO) δ 10.3
(brs, 1H), 9.05 (d, 1H, J ) 8.4 Hz), 8.78 (d, 1H, 4.0 Hz), 8.72 (t,
2H, J ) 5.0 Hz), 8.69-8.67 (m, 3H), 8.58 (m, 2H), 8.47 (d, 1H,
J ) 8.5 Hz), 8.38 (t, 2H, J ) 8.5 Hz), 8.23 (d, 1H, J ) 7.0 Hz),
8.14 (d, 1H, J ) 7.5 Hz), 8.05 (s, 1H), 8.03 (d, 1H, J ) 7.5 Hz),
7.83-7.66 (m, 8H), 7.55 (t, 1H, J ) 7.5 Hz), 7.49-7.45 (m, 3H),
7.27 (t, 1H, J ) 8.0 Hz), 7.06 (s, 1H), 7.01 (t, 1H, J ) 7.5 Hz),
6.98-6.87 (m, 6H), 6.80 (t, 1H, J ) 7.5 Hz), 6.57 (d, 1H, J ) 7.5
Hz), 5.86 (d, 2H, J ) 8.0 Hz), 5.54 (s, 1H), 5.30 (s, 1H), 5.19 (s,
1H), 4.05 (s, 1H), 3.95 (s, 2H), 3.57 (s, 3H), 3.42 (s, 3H), 3.39 (s,
3H), 2.20 (s, 1H), 2.15 (s, 1H), 1.41 (s, 1H); 19F NMR (376 MHz,
THF-d8/MeCN-d3/CDCl3 (9:1:3 vol)/1 atm CO) δ -73.6 ppm (d,
6F, JFP ) 708 Hz); HR-MS (ESI+) m/z ) 1491.3596 [M - PF6]+
(calcd for C84H60CuF6FeN16O5 - PF6 1491.3678); UV/vis (CH2-
Cl2) λmax (10-3ꢀ, M-1 cm-1) 426 (228), 534 (9).
R3-(o-4-(3-Methylimidazolyl)-amidophenyl)-â-(o-3-(1-(5-p-io-
dophenyl)imidazolylmethyl)benzamidophenyl)-porphyrin (R3-
Acknowledgment. R.A.D. and N.K.D. are grateful for a
Lavoisier Fellowship and a Stanford Graduate Fellowship,
respectively. Dr. Allis Chien and the SUMS are thanked for
Mass Spectrometry Analysis. Acknowledgment is given to NIH
Grant 5R01 GM-17880-35 for funding.
1
(N-MeIm)âI-T, 24a: H NMR (500 MHz, CDCl3) δ 8.85 (m,
9H), 8.53 (d, 2H, J ) 8.0 Hz), 8.40 (d, 1H, J ) 8.0 Hz), 8.07 (m,
3H), 7.99 (d, 1H, J ) 8.0 Hz), 7.84 (m, 4H), 7.78 (s, 2H), 7.60 (t,
1H, J ) 7.5 Hz), 7.55 (m, 4H), 7.41 (s, 1H), 6.99 (d, 2H, J ) 8.5
Hz), 6.92 (m, 4H), 6.82 (s, 1H), 6.68 (s, 1H), 6.31 (t, 1H, J ) 8.0
Hz), 6.20 (m, 3H), 6.15 (d, 1H, J ) 8.5 Hz), 5.40 (s, 2H), 5.35 (s,
1H), 3.96 (s, 2H), 3.58 (s, 3H), 3.56 (s, 6H), -2.54 (s, 2H); MS
(ESI+) m/z ) 1385.6 (calcd for C76H57IN16O4 1385.4); UV/vis (CH2-
Cl2) λmax (10-3ꢀ, M-1 cm-1) 424 (274), 518 (9). HPLC-MS (200
µL/min, mobile phase H2O/CH3CN, gradient 2-95%, 35 min);
Supporting Information Available: Experimental procedures
and characterization data for compounds 1-35. This material is
available free of charge via the Internet at http://pubs.acs.org.
JO062349W
2802 J. Org. Chem., Vol. 72, No. 8, 2007